2076975 2077203
최종편집 2024-03-29 00:50 (금)
3 trillion won shorted in the pharmaceutical sector for 99 trading days after the resumption of short selling
상태바
3 trillion won shorted in the pharmaceutical sector for 99 trading days after the resumption of short selling
  • Hyeokgi Lee, Newsmp
  • 승인 2021.09.27 17:28
  • 댓글 0
이 기사를 공유합니다

7.1% in the securities market, similar to the market cap of the pharmaceutical companies
Celltrion KRW 705.1 billionㆍSamsung Biologics KRW 608.8 billionㆍShin Poong     Pharmaceutical KRW 520.8 billion

Trading value for shorting in the pharmaceutical sector in KOSPI exceeded 3 trillion won for a total of 99 trading days until 24 September after the partial resumption of short selling on 3 May.

During the same period, the total short selling value in the KOSPI market was KRW 43.1888 trillion, accounting for 7.1% of short selling transactions in the pharmaceutical sector.

It is almost the same as the KOSPI pharmaceuticals market cap (based on the 24 September closing price, 6.9%).

Among the pharmaceutical industry index, Celltrion’s short sale transaction value was the largest at KRW 705.1 billion, followed by Samsung Biologics with KRW 608.8 billion.

Shin Poong Pharmaceutical saw KRW 520.8 billion shorted among traditional pharmaceutical stocks, and SK Bioscience KRW 454 billion.

Green Cross exceeded KRW 100 billion with KRW 166.5 billion, Hanmi Pharmaceutical KRW 111.3 billion, and Bukwang Pharmaceutical KRW 105 billion.

Hanmi Science, which was excluded from the pharmaceutical index, also surpassed KRW 100 billion with KRW 104.7 billion, and eight pharmaceutical stocks recorded an average of more than KRW 1 billion in short selling transactions per trading day.

Moreover, Daewoong exceeded KRW 50 billion with KRW 87.6 billion, Yuhan Corporation with KRW 86.2 billion, Daewoong Pharmaceutical with KRW 62.5 billion, HanAll Biopharma with KRW 56.6 billion, and Green Cross Holdings with KRW 51.7 billion.

Il-Yang Pharmaceutical had KRW 49.3 billion shorted, Chong Kun Dang Pharmaceutical KRW 43.5 billion shorted, Boryung Pharmaceutical KRW 38.3 billion shorted, Yungjin Pharm. KRW 27 billion shorted and JW Pharmaceutical KRW 25.8 billion shorted.
 


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.